Apollo Medical Holdings Inc
NASDAQ:ASTH

Watchlist Manager
Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc
NASDAQ:ASTH
Watchlist
Price: 42.11 USD Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Apollo Medical Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one ASTH stock under the Base Case scenario is 57.11 USD. Compared to the current market price of 42.11 USD, Apollo Medical Holdings Inc is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ASTH Intrinsic Value
57.11 USD
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Apollo Medical Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ASTH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ASTH?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Apollo Medical Holdings Inc

Provide an overview of the primary business activities
of Apollo Medical Holdings Inc.

What unique competitive advantages
does Apollo Medical Holdings Inc hold over its rivals?

What risks and challenges
does Apollo Medical Holdings Inc face in the near future?

Summarize the latest earnings call
of Apollo Medical Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Apollo Medical Holdings Inc.

Provide P/S
for Apollo Medical Holdings Inc.

Provide P/E
for Apollo Medical Holdings Inc.

Provide P/OCF
for Apollo Medical Holdings Inc.

Provide P/FCFE
for Apollo Medical Holdings Inc.

Provide P/B
for Apollo Medical Holdings Inc.

Provide EV/S
for Apollo Medical Holdings Inc.

Provide EV/GP
for Apollo Medical Holdings Inc.

Provide EV/EBITDA
for Apollo Medical Holdings Inc.

Provide EV/EBIT
for Apollo Medical Holdings Inc.

Provide EV/OCF
for Apollo Medical Holdings Inc.

Provide EV/FCFF
for Apollo Medical Holdings Inc.

Provide EV/IC
for Apollo Medical Holdings Inc.

Show me price targets
for Apollo Medical Holdings Inc made by professional analysts.

What are the Revenue projections
for Apollo Medical Holdings Inc?

How accurate were the past Revenue estimates
for Apollo Medical Holdings Inc?

What are the Net Income projections
for Apollo Medical Holdings Inc?

How accurate were the past Net Income estimates
for Apollo Medical Holdings Inc?

What are the EPS projections
for Apollo Medical Holdings Inc?

How accurate were the past EPS estimates
for Apollo Medical Holdings Inc?

What are the EBIT projections
for Apollo Medical Holdings Inc?

How accurate were the past EBIT estimates
for Apollo Medical Holdings Inc?

Compare the revenue forecasts
for Apollo Medical Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Apollo Medical Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Apollo Medical Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Apollo Medical Holdings Inc compared to its peers.

Compare the P/E ratios
of Apollo Medical Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Apollo Medical Holdings Inc with its peers.

Analyze the financial leverage
of Apollo Medical Holdings Inc compared to its main competitors.

Show all profitability ratios
for Apollo Medical Holdings Inc.

Provide ROE
for Apollo Medical Holdings Inc.

Provide ROA
for Apollo Medical Holdings Inc.

Provide ROIC
for Apollo Medical Holdings Inc.

Provide ROCE
for Apollo Medical Holdings Inc.

Provide Gross Margin
for Apollo Medical Holdings Inc.

Provide Operating Margin
for Apollo Medical Holdings Inc.

Provide Net Margin
for Apollo Medical Holdings Inc.

Provide FCF Margin
for Apollo Medical Holdings Inc.

Show all solvency ratios
for Apollo Medical Holdings Inc.

Provide D/E Ratio
for Apollo Medical Holdings Inc.

Provide D/A Ratio
for Apollo Medical Holdings Inc.

Provide Interest Coverage Ratio
for Apollo Medical Holdings Inc.

Provide Altman Z-Score Ratio
for Apollo Medical Holdings Inc.

Provide Quick Ratio
for Apollo Medical Holdings Inc.

Provide Current Ratio
for Apollo Medical Holdings Inc.

Provide Cash Ratio
for Apollo Medical Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Apollo Medical Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Apollo Medical Holdings Inc?

What is the current Free Cash Flow
of Apollo Medical Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Apollo Medical Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Apollo Medical Holdings Inc

Balance Sheet Decomposition
Apollo Medical Holdings Inc

Current Assets 597m
Cash & Short-Term Investments 350.3m
Receivables 226.1m
Other Current Assets 20.5m
Non-Current Assets 688.4m
Long-Term Investments 43.5m
PP&E 45.3m
Intangibles 518.8m
Other Non-Current Assets 80.8m
Current Liabilities 312.9m
Accounts Payable 60.4m
Accrued Liabilities 22.7m
Other Current Liabilities 229.8m
Non-Current Liabilities 267.8m
Long-Term Debt 423.9m
Other Non-Current Liabilities -156m
Efficiency

Earnings Waterfall
Apollo Medical Holdings Inc

Revenue
1.7B USD
Cost of Revenue
-1.5B USD
Gross Profit
259.9m USD
Operating Expenses
-175.1m USD
Operating Income
84.8m USD
Other Expenses
-22.3m USD
Net Income
62.5m USD

Free Cash Flow Analysis
Apollo Medical Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Astrana Health began 2024 with notable financial and operational achievements. The company reported a 20% increase in total revenue, reaching $404 million, and a 42% growth in adjusted EBITDA, now at $42.2 million, yielding a margin of 10.4%. This growth was driven by a mix of organic membership expansion and acquisitions. Membership grew by 10% organically, excluding strategic acquisitions. The company also foresees a single-digit uplift in Q2 revenue due to acquisitions. Astrana reaffirmed its full-year guidance, highlighting a strong and sustainable business trajectory. Key investments in technology and new market operations are expected to continue driving growth and profitability.

What is Earnings Call?
Fundamental Scores

ASTH Profitability Score
Profitability Due Diligence

Apollo Medical Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
50/100
Profitability
Score

Apollo Medical Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ASTH Solvency Score
Solvency Due Diligence

Apollo Medical Holdings Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
57/100
Solvency
Score

Apollo Medical Holdings Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ASTH Price Targets Summary
Apollo Medical Holdings Inc

Wall Street analysts forecast ASTH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASTH is 64.76 USD with a low forecast of 33.71 USD and a high forecast of 90.3 USD.

Lowest
Price Target
33.71 USD
20% Downside
Average
Price Target
64.76 USD
54% Upside
Highest
Price Target
90.3 USD
114% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ASTH?

Click here to dive deeper.

Dividends

Apollo Medical Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ASTH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

2B USD

Dividend Yield

0%

Description

Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,133 full-time employees. The firm through its subsidiary provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements. To implement a patient-centered, physician-centric experience, the Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated independent practice associations (IPAs), outpatient clinics, and hospitalists that coordinates the care of patients in hospitals.

Contact

CALIFORNIA
Alhambra
1668 S Garfield Ave Fl 2nd
+16262820288.0
apollomed.net

IPO

1999-04-09

Employees

1 133

Officers

Co-Founder & Executive Chairman
Dr. Kenneth T. Sim M.D.
President & CEO
Mr. Brandon K. Sim M.S.
Co-Founder & Vice Chairman
Dr. Thomas S. Lam M.D., M.P.H.
CFO, COO & Corporate Secretary
Mr. Chandan Basho M.B.A.
Senior Vice President of Health Affairs
Dr. WaiChow Young M.D., M.P.H.
Chief Accounting Officer
Mr. John Vong CPA, CGMA, M.B.A.
Show More
Vice President of People & Operations
Ms. Rita Pew M.B.A.
Chief Quality Officer
Dr. Jeremy R. Jackson M.D.
President of Provider Solutions
Mr. Neil Ahuja
Chief Medical Officer for Texas
Dr. Carlos Palacios M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ASTH stock?

The intrinsic value of one ASTH stock under the Base Case scenario is 57.11 USD.

Is ASTH stock undervalued or overvalued?

Compared to the current market price of 42.11 USD, Apollo Medical Holdings Inc is Undervalued by 26%.

Back to Top